Functional polymorphisms in the promoter regions of MMP2 and MMP3 are not associated with melanoma progression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-5751
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Functional polymorphisms in the promoter regions of MMP2 and MMP3 are not associated with melanoma progression ; volume:6 ; number:1 ; day:24 ; month:10 ; year:2007 ; pages:1-8 ; date:12.2007
Journal of negative results in biomedicine ; 6, Heft 1 (24.10.2007), 1-8, 12.2007
- Creator
-
Cotignola, Javier
- Contributor
-
Roy, Pampa
Patel, Ami
Ishill, Nicole
Shah, Shivang
Houghton, Alan
Coit, Daniel
Halpern, Allan
Busam, Klaus
Berwick, Marianne
Orlow, Irene
SpringerLink (Online service)
- DOI
-
10.1186/1477-5751-6-9
- URN
-
urn:nbn:de:1111-201607092375
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cotignola, Javier
- Roy, Pampa
- Patel, Ami
- Ishill, Nicole
- Shah, Shivang
- Houghton, Alan
- Coit, Daniel
- Halpern, Allan
- Busam, Klaus
- Berwick, Marianne
- Orlow, Irene
- SpringerLink (Online service)
Other Objects (12)
IRF5 gene polymorphisms in melanoma
SNPPromoter: a database of human SNPs (Single Nucleotide Polymorphisms) within the putative promoter regions
Sequence Analysis In Promoter Regions
GSTT2 promoter polymorphisms and colorectal cancer risk
Melanoma-specific mutation hotspots in distal, non-coding, promoter-interacting regions implicate novel candidate driver genes
Genome-wide promoter methylation profiling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival
Telomerase reverse transcriptase promoter mutations in melanoma, non-melanoma skin cancer and glioma
Hypoxia-dependent drivers of melanoma progression
Exome sequencing in primary melanoma identifies novel drivers of melanoma progression
Role of galectin-3 in melanoma progression
Role of galectin-3 in melanoma progression
SIRT1 regulates Mxd1 during malignant melanoma progression
IRF5 gene polymorphisms in melanoma
SNPPromoter: a database of human SNPs (Single Nucleotide Polymorphisms) within the putative promoter regions
Sequence Analysis In Promoter Regions
GSTT2 promoter polymorphisms and colorectal cancer risk
Melanoma-specific mutation hotspots in distal, non-coding, promoter-interacting regions implicate novel candidate driver genes
Genome-wide promoter methylation profiling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival
Telomerase reverse transcriptase promoter mutations in melanoma, non-melanoma skin cancer and glioma
Hypoxia-dependent drivers of melanoma progression
Exome sequencing in primary melanoma identifies novel drivers of melanoma progression
Role of galectin-3 in melanoma progression
Role of galectin-3 in melanoma progression
SIRT1 regulates Mxd1 during malignant melanoma progression
IRF5 gene polymorphisms in melanoma
SNPPromoter: a database of human SNPs (Single Nucleotide Polymorphisms) within the putative promoter regions
Sequence Analysis In Promoter Regions
GSTT2 promoter polymorphisms and colorectal cancer risk
Melanoma-specific mutation hotspots in distal, non-coding, promoter-interacting regions implicate novel candidate driver genes
Genome-wide promoter methylation profiling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival
Telomerase reverse transcriptase promoter mutations in melanoma, non-melanoma skin cancer and glioma
Hypoxia-dependent drivers of melanoma progression
Exome sequencing in primary melanoma identifies novel drivers of melanoma progression
Role of galectin-3 in melanoma progression
Role of galectin-3 in melanoma progression